DAA948 |
Volume of perivascular space around thymus increases |
Physiological |
thymus |
Human |
— |
— |
|
DAA2070 |
von Willebrand factor A domain containing 5A decreases with age |
Molecular |
ovary |
Human |
VWA5A |
56.0% Decrease Gene Expression Level |
|
DAA195 |
v-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein) |
Molecular |
brain |
Human |
RALB |
7.0% Decrease Gene Expression Level |
|
DAA2078 |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) increases with age |
Molecular |
ovary |
Human |
RELA |
60.0% Increase Gene Expression Level |
|
DAA703 |
Wall increases in thickness |
Physiological |
left ventricle |
Human |
— |
— |
|
DAA250 |
WD repeat and SOCS box-containing 2 |
Molecular |
brain |
Human |
WSB2 |
5.0% Decrease Gene Expression Level |
|
DAA436 |
WD repeat domain 12 |
Molecular |
skeletal muscle |
Human |
WDR12 |
3.0% Decrease Gene Expression Level |
|
DAA846 |
Weakening of intestinal wall |
Physiological |
large intestine |
Human |
— |
— |
|
DAA826 |
Weaker digestive tract muscle contractions |
Physiological |
alimentary system, smooth muscle |
Human |
— |
— |
|
DAA826 |
Weaker digestive tract muscle contractions |
Physiological |
alimentary system, smooth muscle |
Human |
— |
— |
|
DAA730 |
White matter volume decreases |
Physiological |
white matter |
Human |
— |
— |
|
DAA884 |
Widespread degeneration of glomerular blood vessels |
Physiological |
renal vasculature |
Human |
— |
— |
|
DAA2391 |
WNT1 inducible signaling pathway protein 2 precursor decreases with age |
Molecular |
dermis |
Human |
WISP2 |
17.7% Decrease DNA Methylation |
|
DAA2440 |
WNT1 inducible signaling pathway protein 2 precursor decreases with age |
Molecular |
mesenchymal stem cell |
Human |
WISP2 |
23.5% Decrease DNA Methylation |
|
DAA1003 |
Wrinkles |
Physiological |
skin |
Human |
— |
— |
|
DAA251 |
WW domain containing transcription regulator 1 |
Molecular |
brain |
Human |
WWTR1 |
24.0% Increase Gene Expression Level |
|
DAA353 |
xeroderma pigmentosum, complementation group C |
Molecular |
skeletal muscle |
Human |
XPC |
7.0% Increase Gene Expression Level |
|
DAA586 |
xeroderma pigmentosum, complementation group C |
Molecular |
skeletal muscle |
Human |
XPC |
6.0% Increase Gene Expression Level |
|
DAA255 |
zer-1 homolog (C. elegans) |
Molecular |
brain |
Human |
ZER1 |
16.0% Decrease Gene Expression Level |
|
DAA2113 |
zinc finger and BTB domain containing 10 decreases with age |
Molecular |
ovary |
Human |
ZBTB10 |
59.4% Decrease Gene Expression Level |
|
DAA330 |
zinc finger and BTB domain containing 4 |
Molecular |
skeletal muscle |
Human |
ZBTB4 |
2.0% Increase Gene Expression Level |
|
DAA26 |
zinc finger, CCHC domain containing 24 |
Molecular |
brain |
Human |
ZCCHC24 |
15.0% Increase Gene Expression Level |
|
DAA513 |
zinc finger, FYVE domain containing 20 |
Molecular |
skeletal muscle |
Human |
ZFYVE20 |
3.0% Increase Gene Expression Level |
|
DAA60 |
zinc finger, MIZ-type containing 2 |
Molecular |
brain |
Human |
ZMIZ2 |
17.0% Decrease Gene Expression Level |
|
DAA2397 |
zinc finger, MYND-type containing 8 increases with age |
Molecular |
dermis |
Human |
ZMYND8 |
19.5% Increase DNA Methylation |
|